| Michelle Arnott, CNM | |
|
1 Windflower, Coto De Caza, CA 92679-4714 | |
| (949) 940-6311 | |
| Not Available |
| Full Name | Michelle Arnott |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 1 Windflower, Coto De Caza, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649812587 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 236066 (California) | Primary |
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Scientists from the UNC School of Medicine have developed a new tool for studying a key process in cells called G-protein signaling, which plays a central role in the normal functioning of cells and can go awry to cause severe disease, including cancers.
Pulse Data International today introduced the world's smallest handheld Braille device for the blind. The BrailleNote PK weighs less than a pound and has dimensions of 6.8 inches by 3.6 inches by 1.3 inches.
After reviewing thousands of case studies going back 25 years across six countries, generalizable survival data is now available for the first time to estimate how long hip and knee replacements are likely to last.
Several patients with recurring glioblastoma, a deadly brain cancer, survived for more than a year in a clinical trial believed to be the first to use comprehensive DNA and RNA sequencing of a patient's tumor to inform treatment for these patients in real-time.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Arnott, CNM 1 Windflower, Coto De Caza, CA 92679-4714 Ph: (949) 940-6311 | Michelle Arnott, CNM 1 Windflower, Coto De Caza, CA 92679-4714 Ph: (949) 940-6311 |
News Archive
Scientists from the UNC School of Medicine have developed a new tool for studying a key process in cells called G-protein signaling, which plays a central role in the normal functioning of cells and can go awry to cause severe disease, including cancers.
Pulse Data International today introduced the world's smallest handheld Braille device for the blind. The BrailleNote PK weighs less than a pound and has dimensions of 6.8 inches by 3.6 inches by 1.3 inches.
After reviewing thousands of case studies going back 25 years across six countries, generalizable survival data is now available for the first time to estimate how long hip and knee replacements are likely to last.
Several patients with recurring glioblastoma, a deadly brain cancer, survived for more than a year in a clinical trial believed to be the first to use comprehensive DNA and RNA sequencing of a patient's tumor to inform treatment for these patients in real-time.
› Verified 5 days ago